HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis.

Abstract
Nonalcoholic fatty liver disease (NAFLD) is characterized by abnormal accumulation of triglycerides (TG) in the liver and other metabolic syndrome symptoms, but its molecular genetic causes are not completely understood. Here, we show that mice deficient for ubiquitin ligase (E3) Smad ubiquitin regulatory factor 1 (Smurf1) spontaneously develop hepatic steatosis as they age and exhibit the exacerbated phenotype under a high-fat diet (HFD). Our data indicate that loss of Smurf1 up-regulates the expression of peroxisome proliferator-activated receptor γ (PPARγ) and its target genes involved in lipid synthesis and fatty acid uptake. We further show that PPARγ is a direct substrate of Smurf1-mediated non-proteolytic lysine 63 (K63)-linked ubiquitin modification that suppresses its transcriptional activity, and treatment of Smurf1-deficient mice with a PPARγ antagonist, GW9662, completely reversed the lipid accumulation in the liver. Finally, we demonstrate an inverse correlation of low SMURF1 expression to high body mass index (BMI) values in human patients, thus revealing a new role of SMURF1 in NAFLD pathogenesis.
AuthorsKun Zhu, Yi Tang, Xuan Xu, Hien Dang, Liu-Ya Tang, Xiang Wang, Xin Wei Wang, Ying E Zhang
JournalPLoS biology (PLoS Biol) Vol. 16 Issue 12 Pg. e3000091 (12 2018) ISSN: 1545-7885 [Electronic] United States
PMID30566427 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Fatty Acids
  • PPAR gamma
  • Triglycerides
  • SMURF1 protein, human
  • Smurf1 protein, mouse
  • Ubiquitin-Protein Ligases
Topics
  • Animals
  • Cell Line
  • Diet, High-Fat
  • Fatty Acids (metabolism)
  • Fatty Liver (metabolism, physiopathology, prevention & control)
  • Humans
  • Liver (metabolism, physiology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Non-alcoholic Fatty Liver Disease (metabolism)
  • PPAR gamma (metabolism)
  • Triglycerides (metabolism)
  • Ubiquitin-Protein Ligases (metabolism, physiology)
  • Ubiquitination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: